Home/Filings/4/0001651308-22-000034
4//SEC Filing

Riva Alessandro 4

Accession 0001651308-22-000034

CIK 0001651308other

Filed

Mar 1, 7:00 PM ET

Accepted

Mar 2, 5:10 PM ET

Size

6.1 KB

Accession

0001651308-22-000034

Insider Transaction Report

Form 4
Period: 2022-02-28
Transactions
  • Award

    Share Option (Right to Buy)

    2022-02-28+22,58122,581 total
    Exercise: $16.22Exp: 2032-02-27Ordinary Shares (22,581 underlying)
Footnotes (2)
  • [F1]The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each American Depositary Share represents 13 ordinary shares.
  • [F2]The option shall become exercisable in full upon the earlier to occur of the first anniversary of the grant date or the date of the next annual general meeting; provided, however, that all vesting shall cease if the Reporting Person resigns from the board of directors or otherwise ceases to serve as a director, unless the board determines otherwise. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events. The option was granted under the Company's Independent Director Compensation Policy, as amended.

Issuer

BeiGene, Ltd.

CIK 0001651308

Entity typeother

Related Parties

1
  • filerCIK 0001867172

Filing Metadata

Form type
4
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 5:10 PM ET
Size
6.1 KB